Moclobemide Sandoz Ltd

Moclobemide, the active ingredient in Moclobemide Sandoz Ltd, is a reversible monoamine oxidase inhibitor presented as an oral dosage form for oral use. It is prescribed for major depressive disorder, dysthymia, and social anxiety disorder in adult patients, helping to improve mood and reduce anxiety by increasing central neurotransmitter levels.

GNH USA supplies Moclobemide Sandoz Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclobemide is used in the treatment of mood and anxiety disorders that involve dysregulation of monoamine neurotransmitters.

- Major depressive disorder: alleviates depressive symptoms by enhancing serotonin, norepinephrine and dopamine activity. - Dysthymia: reduces chronic low‑grade depressive mood and improves functional capacity. - Social anxiety disorder: lessens anxiety in social situations through increased central monoamine levels.

Moclobemide may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Headache: transient cranial pain. - Insomnia: difficulty sleeping. - Dizziness: light‑headedness on standing.

Serious or Rare Side Effects: - Hypertensive crisis: sudden severe rise in blood pressure, especially after tyramine intake. - Serotonin syndrome: agitation, fever, muscle rigidity. - Severe liver injury: jaundice or marked enzyme elevation.

Before prescribing Moclobemide, clinicians should consider several safety measures.

- Assess cardiovascular status: evaluate blood pressure before initiating therapy. - Avoid high‑tyramine foods: limit aged cheeses, cured meats, fermented products. - Monitor for signs of serotonin syndrome: especially when combined with serotonergic agents. - Review hepatic function: adjust use in patients with liver impairment. - Store at below 25°C: keep in original container, protect from moisture and light.

Moclobemide interacts with several drug classes; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Tyramine‑rich foods: can precipitate hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Tricyclic antidepressants: increased serotonergic activity.

Moderate Interactions (Monitor Closely): - Sympathomimetic agents (e.g., pseudoephedrine): may raise blood pressure. - Opioids such as meperidine: potential for serotonin toxicity. - Certain antihypertensives: may blunt blood‑pressure‑lowering effect.